About Enhancer
| Enhancer ID: | E_02_0505 |
| Species: | human |
| Position : | chr3:133743395-133745395   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Obesity (dio), type 2 diabetes, cardiovascular disease, hypertension, cancer |
| Pubmed ID: | 30057115 |
| Enhancer experiment: | GRO-seq,Western Blot,ChIP-seq |
| Enhancer experiment description: | The cistromes include functional enhancer sites, where TF binding leads to regulation of gene transcription over large genomic distances (Levine et al., 2014). |
About Target gene
| Target gene : | TF |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | The cistromes include functional enhancer sites, where TF binding leads to regulation of gene transcription over large genomic distances (Levine et al., 2014). |
About TF
| TF name : | -- |
| TF experiment: | GRO-seq,Western Blot,ChIP-seq |
| TF experiment description: | The cistromes include functional enhancer sites, where TF binding leads to regulation of gene transcription over large genomic distances (Levine et al., 2014). |
About Function
| Enhancer function : | The cistromes include functional enhancer sites, where TF binding leads to regulation of gene transcription over large genomic distances (Levine et al., 2014). |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
The cistromes include functional enhancer sites, where TF binding leads to regulation of gene transcription over large genomic distances (Levine et al., 2014). |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene